Revenue | ₹8.84Cr |
Net Profits | ₹0.41Cr |
Net Profit Margins | 4.64% |
Welcure Drugs & Pharmaceuticals Ltd’s revenue jumped 22000% since last year same period to ₹8.84Cr in the Q3 2024-2025. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated -63.99% fall in its revenue since last 3-months.
Welcure Drugs & Pharmaceuticals Ltd’s net profit jumped 1466.67% since last year same period to ₹0.41Cr in the Q3 2024-2025. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated -77.72% fall in its net profits since last 3-months.
Welcure Drugs & Pharmaceuticals Ltd’s net profit margin jumped 106.18% since last year same period to 4.64% in the Q3 2024-2025. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated -38.12% fall in its net profit margins since last 3-months.
The revenue for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹8.84Cr.
The net profit for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.41Cr.
The net profit margin for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was 4.64%.
The revenue for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was ₹0.04Cr.
The net profit for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was ₹0.03Cr.
The net profit margin for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was -75%.